LDN212854
LDN-212854 is a novel BMP inhibitor that exhibits substantially greater selectivity for BMP versus the TGF-β type I receptors; possesses a bias towards ALK2 (IC50=1.3 nM) versus ALK1 and ALK3 compared to other inhibitors.
Product Specifications
CAS Number
1432597-26-6
Product Name Alternative
LDN212854 | LDN 212854 | LDN-212854
Purity
>98% (HPLC)
Solubility
DMSO: 81 mg/mL warmed (199.27 mM)
Smiles
C12=C (C3=C4N=CC (C5=CC=C (N6CCNCC6) C=C5) =CN4N=C3) C=CC=C1N=CC=C2
Molecular Formula
C25H22N6
Molecular Weight
406.48
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
5- (6- (4- (piperazin-1-yl) phenyl) pyrazolo[1,5-a]pyrimidin-3-yl) quinoline
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682716-500 1x 500 µL
PAPP-A / Pappalysin-1 (Marker of Atherosclerosis and Aneuploid Fetus) (PAPPA/2716), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680444-100 1x 100 µL
Pmel17 / gp100 / SILV (HMB45), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
